Egetis Therapeutics AB a annoncé avoir finalisé le dépôt progressif de la demande d'autorisation de mise sur le marché auprès ...
Stockholm, Sweden, February 4, 2026. Egetis Therapeutics AB (publ) ("Egetis" or the "Company") (NASDAQ Stockholm: EGTX), today noted that the U.S. Food and Drug Administration's (FDA's) Rare Pediatric ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results